Related Experiment Video
Updated: Jul 10, 2026
11:56
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Telavancin: a novel lipoglycopeptide antimicrobial agent
Ryan J Attwood1, Kerry L LaPlante
1Henry Ford Hospital, Detroit, MI, USA.
Summary
Telavancin is a new lipoglycopeptide antimicrobial for multidrug-resistant gram-positive infections. It shows efficacy comparable to standard treatments and may offer an alternative for MRSA infections.
Area of Science:
- Pharmacology
- Antimicrobial Agents
Background:
- Multidrug-resistant gram-positive infections pose a significant therapeutic challenge.
- Vancomycin is a standard treatment, but resistance and suboptimal outcomes necessitate new agents.
Purpose of the Study:
- To review the pharmacology, activity, pharmacokinetics, pharmacodynamics, clinical efficacy, safety, dosage, and therapeutic role of telavancin.
- To evaluate telavancin as a potential treatment for gram-positive infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA).
Main Methods:
- Review of existing literature on telavancin.
- Analysis of data from Phase II and Phase III clinical trials for complicated skin and soft-tissue infections.
- Examination of preclinical data for other indications like pneumonia and bacteremia.
Main Results:
- Telavancin inhibits bacterial cell-wall biosynthesis and disrupts the cell membrane, exhibiting concentration-dependent bactericidal activity.
- Clinical trials demonstrated telavancin was non-inferior to standard treatment for complicated skin and soft-tissue infections.
- Pharmacokinetic studies show high protein binding and renal elimination, requiring dosage adjustments in renal impairment.
Conclusions:
- Telavancin is a promising lipoglycopeptide antimicrobial agent for treating multidrug-resistant gram-positive infections.
- It offers a potential alternative to vancomycin, particularly for MRSA-associated infections.
- Further trials are planned to assess its efficacy in hospital-acquired pneumonia.
Related Concept Videos
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:28Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
01:23Antimicrobial Proteins
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...